Durvalumab‐induced lesions of bronchiolitis and fully reversible bronchiectasis in a patient with non‐small cell lung cancer: A case report
Author:
Affiliation:
1. Department of Oncology Augustin Morvan Hospital, Brest University Hospital Brest France
2. Department of Pulmonology Annecy Genevois Hospital Annecy France
Publisher
Wiley
Subject
Pulmonary and Respiratory Medicine,Oncology,General Medicine
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/1759-7714.13862
Reference17 articles.
1. Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer
2. Immune-Related Adverse Events in the Setting of PD-1/L1 Inhibitor Combination Therapy
3. Management of toxicities from immunotherapy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
4. Management of pulmonary toxicity associated with immune checkpoint inhibitors
5. Fatal Airway Inflammation Induced by Pembrolizumab in a Patient With NSCLC
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A case of eosinophilic bronchiolitis after the initiation of immune checkpoint inhibitor;Thoracic Cancer;2023-05-18
2. Sarcoidosis and Airway Disease After Immune Checkpoint Inhibitor Therapy: Case Study and Review of the Literature;Journal of Immunotherapy and Precision Oncology;2023-03-21
3. Airway disorders associated with immune checkpoint inhibitor therapy: Two case reports and a systematic review;Seminars in Oncology;2022-12
4. Multiple drugs;Reactions Weekly;2021-10
5. Durvalumab‐induced lesions of bronchiolitis and fully reversible bronchiectasis in a patient with non‐small cell lung cancer: A case report;Thoracic Cancer;2021-02-23
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3